| NDC Code | 0574-0931-25 |
|---|
| Package Description | 1 VIAL, SINGLE-DOSE in 1 CARTON (0574-0931-25) / 25 mL in 1 VIAL, SINGLE-DOSE |
|---|
| Product NDC | 0574-0931 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Doxorubicin Hydrochloride |
|---|
| Non-Proprietary Name | Doxorubicin Hydrochloride |
|---|
| Dosage Form | INJECTION, SUSPENSION, LIPOSOMAL |
|---|
| Usage | INTRAVENOUS |
|---|
| Start Marketing Date | 20211025 |
|---|
| End Marketing Date | 20240430 |
|---|
| Marketing Category Name | ANDA |
|---|
| Application Number | ANDA207228 |
|---|
| Manufacturer | Padagis US LLC |
|---|
| Substance Name | DOXORUBICIN HYDROCHLORIDE |
|---|
| Strength | 2 |
|---|
| Strength Unit | mg/mL |
|---|
| Pharmacy Classes | Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA] |
|---|